Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study
Gavin R. Graff, Karen Maguiness, John McNamara, Ronald Morton, David Boyd, Katrin Beckmann, Djenane BennettVolume:
32
Year:
2010
Language:
english
Pages:
15
DOI:
10.1016/j.clinthera.2010.01.012
File:
PDF, 307 KB
english, 2010